WELLS FARGO & COMPANY/MN
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in CRNX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,675,039
-$3,816,870 QoQ
Shares Held
73,652
-47.2% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99.7365991419106.ToString("F0")%
Shared 0.ToString("F0")%
None 0.2634008580893934.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. CRNX ranks #53 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in CRNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,675,039 | 73,652 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,491,909 | 139,461 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,110,937 | 98,702 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,590,124 | 90,060 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,068,707 | 91,494 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,159,833 | 100,916 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,337,930 | 84,891 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,266,086 | 72,920 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,222,398 | 68,840 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $745,115 | 20,942 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,540,292 | 51,792 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $795,311 | 44,135 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $497,602 | 30,984 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,631 | 417 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,167 | 976 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,365 | 1,521 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $135,122 | 6,156 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $628,286 | 22,115 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $79,379 | 5,195 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $327,253 | 23,193 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $310,876 | 19,839 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $354,885 | 20,256 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $99,357 | 6,759 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||